BSX

NYSE

BOSTON SCIENTIFIC CORP

Latest disclosureSeptember 3, 2026

Insider score Why 60?: 60/ 100
Qualifying buys · 30d: $0

10 purchases · 0 sales

Price by TradingView

Insider transactions 41

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

No sales match these filters in the loaded filings.

This reflects the filings imported so far, not a complete trading history.

Show all loaded activity

Congress transactions 26

All Congress filings

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a joint account.

Kevin HernReporting House member

Reported amount: $50,001 – $100,000Reported range; exact amount not disclosed.
Trade date: September 9, 2026

Partial sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a partial sale for a joint account.

Kevin HernReporting House member

Reported amount: $50,001 – $100,000Reported range; exact amount not disclosed.
Trade date: September 4, 2026

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a dependent.

Kevin HernReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 3, 2026

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a dependent.

Kevin HernReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 3, 2026

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a dependent.

Kevin HernReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 3, 2026

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a joint account.

Kevin HernReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: August 31, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: August 18, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 27, 2026

Partial sale disclosed

Boston Scientific Corporation Common Stock · Stock

The filing reports a partial sale for a joint account.

John BoozmanReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 4, 2026

Partial sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 5, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 5, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 29, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 19, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 11, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 10, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 30, 2026

Purchase disclosed

Boston Scientific Corporation Common Stock · Stock

The filing reports a purchase for a joint account.

Markwayne MullinReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: December 29, 2025

Partial sale disclosed

Boston Scientific Corp · Stock

The filing reports a partial sale for a joint account.

John BoozmanReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 17, 2025

Partial sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 24, 2025

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 18, 2025

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 31, 2025

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 30, 2025

Sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a sale for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 30, 2025

Purchase disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 17, 2025

Partial sale disclosed

Boston Scientific Corporation Common Stock (BSX) · Stock

The filing reports a partial sale for a joint account.

Kevin HernReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: October 28, 2025

Showing the latest 25 of 26 disclosed trades. Show all 26 trades

Why this buying score?

Qualifying common-equity purchase value

$5,375,903 of common-equity purchase value after transaction-age decay across 180 days.

+25 pts

Distinct buying groups

5 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+19 pts

CEO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+8 pts

Material reported holdings increase

At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.

+8 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000885725
Latest public acceptance: Sep 3, 2026, 08:34 PM UTC
Score calculated: Oct 7, 2026, 12:05 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Why this buying score?

Qualifying common-equity purchase value

$5,375,903 of common-equity purchase value after transaction-age decay across 180 days.

+25 pts

Distinct buying groups

5 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+19 pts

CEO purchase

Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.

+8 pts

Material reported holdings increase

At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.

+8 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000885725
Latest public acceptance: Sep 3, 2026, 08:34 PM UTC
Score calculated: Oct 7, 2026, 12:05 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.